1. Hemostatic biomarkers levels for the identification of cancer patients at higher VTE risk enrolled in the HYPERCAN study. Issue 164 (April 2018) Authors: Verzeroli, C.; Marchetti, M.; Giaccherini, C.; Masci, G.; Celio, L.; Merelli, B.; Sarmiento, R.; Ghilardi, M.; Brevi, S.; Gamba, S.; Milesi, V.; Raffaeli, D.; Russo, L.; Tartari, C.J.; Malighetti, P.; Spinelli, D.; Santoro, A.; De Braud, F.; Labianca, R.; Gasparini, G. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin. (December 2021) Authors: Celio, L.; Cortinovis, D.; Cogoni, A.A.; Cavanna, L.; Martelli, O.; Carnio, S.; Collovà, E.; Bertolini, F.; Petrelli, F.; Cassano, A.; Chiari, R.; Zanelli, F.; Pisconti, S.; Vittimberga, I.; Letizia, A.; Misino, A.; Gernone, A.; Bonizzoni, E.; Pilotto, S.; De Placido, S. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-1a: A prospective study of hemostatic biomarkers to predict early recurrence in high-risk breast cancer women undergoing post-surgical adjuvant systemic therapy. Issue 151 (March 2017) Authors: Marchetti, M.; Masci, G.; Verzeroli, C.; Giaccherini, C.; Celio, L.; Merelli, B.; Sarmiento, R.; Brevi, S.; Gamba, S.; Milesi, V.; Russo, L.; Tartari, C.J.; Malighetti, P.; Spinelli, D.; De Braud, F.; Labianca, R.; Gasparini, G.; Santoro, A.; Falanga, A. Journal: Thrombosis research Issue: Issue 151(2017)Supplement 1 Page Start: S103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Thrombin generation predicts for early recurrence in breast cancer patients undergoing post-surgical adjuvant therapy: results from the HYPERCAN study. Issue 164 (April 2018) Authors: Giaccherini, C.; Marchetti, M.; Verzeroli, C.; Masci, G.; Celio, L.; Merelli, B.; Sarmiento, R.; Brevi, S.; Gamba, S.; Milesi, V.; Raffaeli, D.; Russo, L.; Tartari, C.J.; Malighetti, P.; Spinelli, D.; De Braud, F.; Labianca, R.; Gasparini, G.; Santoro, A.; Giuliani, F. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-83 Assessment model for thrombotic risk in a prospective cohort of newly diagnosed metastatic cancer outpatient candidates for chemotherapy. Issue 200 (April 2021) Authors: Verzeroli, C.; Marchetti, M.; Giaccherini, C.; Russo, L.; Masci, G.; Celio, L.; Sarmiento, R.; Gamba, S.; Tartari, C.J.; Diani, E.; Vignoli, A.; Schillaci, N.; Gomez, P.; Malighetti, P.; Spinelli, D.; Tondini, C.; Barni, S.; Giuliani, F.; Petrelli, F.; D'Alessio, A. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗